Managers / Q3 2024 · view latest →
Forefront Analytics, LLC
CIK 0001696802 · ONE TOWER BRIDGE, 100 FRONT STREET, SUITE 1111, WEST CONSHOHOCKEN, PA, 19428 · 6103413900
Summary
Forefront Analytics, LLC reported $212M in U.S.-listed holdings across 114 positions for Q3 2024.
Its largest position, Nushares Etf Tr, represents 13.7% of the portfolio.
Compared with Q2 2024, the fund opened 3 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 96.9% · $205M
- Common Stock · 2.9% · $6M
- Other · 0.2% · $461,871
- ADR · 0.1% · $138,915
Quarter-over-Quarter Changes full breakdown →
vs Q2 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ABTABBOTT LABS | NEW | +3.9K | 3.9K | +$442,659 | $442,659 |
| MEDTRONIC PLC | NEW | +2.3K | 2.3K | +$209,221 | $209,221 |
| EWEDWARDS LIFESCIENCES CORP | NEW | +3.1K | 3.1K | +$207,343 | $207,343 |
| ISHARES TR | SOLD OUT | −7.2K | 0 | −$361,022 | $0 |
| 4I1PHILIP MORRIS INTL INC | SOLD OUT | −2.7K | 0 | −$277,524 | $0 |
| ATHIRA PHARMA INC | SOLD OUT | −46.6K | 0 | −$123,477 | $0 |
| TVTXTRAVERE THERAPEUTICS INC | SOLD OUT | −13.3K | 0 | −$109,466 | $0 |
| NVDANVIDIA CORPORATION | TRIMMED | −15.5K | 15.6K | −$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ISHARES TR | MSCI USA MMENTM · JPMORGAN USD EMG · MBS ETF · GLB INFRASTR ETF · CORE HIGH DV ETF · IBOXX INV CP ETF · CORE S&P500 ETF · TIPS BD ETF · SHORT TREAS BD · 0-5 YR TIPS ETF · 7-10 YR TRSY BD · 3 7 YR TREAS BD · MSCI USA MIN VOL · MSCI INDIA ETF · FLTG RATE NT ETF | 21.40% | $45M | 443.1K |
| 2 | NUSHARES ETF TR | NUVEEN ESG LRGVL | 13.67% | $29M | 694.6K |
| 3 | VANGUARD INTL EQUITY INDEX F | FTSE EMR MKT ETF · GLB EX US ETF | 7.82% | $17M | 347.5K |
| 4 | SPDR S&P 500 ETF TR | TR UNIT | 5.94% | $13M | 22.0K |
| 5 | PIMCO ETF TR | 15+ YR US TIPS | 5.51% | $12M | 202.2K |
| 6 | SPDR SER TR | FTSE INT GVT ETF · BLOOMBERG HIGH Y · BLOOMBERG INVT | 4.91% | $10M | 238.6K |
| 7 | VANGUARD CHARLOTTE FDS | TOTAL INT BD ETF | 4.90% | $10M | 206.6K |
| 8 | VANGUARD TAX-MANAGED FDS | VAN FTSE DEV MKT | 4.83% | $10M | 193.7K |
| 9 | ESGGFLEXSHARES TRhistory → | STOX GBL ESG SLT | 4.32% | $9M | 53.1K |
| 10 | FIRST TR EXCHANGE-TRADED FD | NO AMER ENERGY | 3.49% | $7M | 220.0K |
| 11 | BARCLAYS BANK PLC | DJUBS CMDT ETN36 | 3.34% | $7M | 219.9K |
| 12 | VANGUARD WORLD FD | EXTENDED DUR | 3.14% | $7M | 83.6K |
| 13 | DBX ETF TR | XTRACK MSCI EAFE | 2.95% | $6M | 148.6K |
| 14 | INVESCO EXCH TRADED FD TR II | SR LN ETF | 2.68% | $6M | 270.8K |
| 15 | VTVVANGUARD INDEX FDS | REAL ESTATE ETF · VALUE ETF · SMALL CP ETF | 2.47% | $5M | 41.0K |
| 16 | NVDANVIDIA CORPORATION | COM | 0.89% | $2M | 15.5K |
| 17 | ISHARES INC | CUR HD MSCI EM | 0.84% | $2M | 62.5K |
| 18 | INVESCO EXCHANGE TRADED FD T | DORSEY WRIGHT MO | 0.81% | $2M | 16.7K |
| 19 | WISDOMTREE TR | US SMALLCAP FUND | 0.54% | $1M | 21.9K |
| 20 | SELECT SECTOR SPDR TR | RL EST SEL SEC | 0.47% | $999,102 | 22.4K |
| 21 | JPMJPMORGAN CHASE & CO. | COM | 0.33% | $689,226 | 3.3K |
| 22 | PROSHARES TR | PSHS ULTRUSS2000 | 0.30% | $627,145 | 14.6K |
| 23 | INVESCO EXCH TRD SLF IDX FD | INVSCO 30 CORP | 0.23% | $492,887 | 29.1K |
| 24 | DEDEERE & CO | COM | 0.22% | $464,939 | 1.1K |
| 25 | SCHWAB STRATEGIC TR | US SML CAP ETF | 0.22% | $464,137 | 9.0K |
| 26 | ABTABBOTT LABS | COM | 0.19% | $410,276 | 3.6K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $110M | 39 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $113M | 47 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 46 | Nov 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $90M | 47 | Aug 14, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2025 | $87M | 72 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $215M | 113 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $212M | 114 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $209M | 114 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $206M | 113 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $203M | 112 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $176M | 67 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $175M | 115 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $194M | 138 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $188M | 130 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $188M | 115 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $206M | 114 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $269M | 119 | May 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $299M | 109 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $274M | 118 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $252M | 113 | Aug 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $235M | 114 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $230M | 109 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $214M | 98 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | Under review | 92 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | Under review | 179 | May 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $257M | 77 | Feb 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $243M | 76 | Nov 5, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $235M | 69 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $157M | 69 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $181M | 73 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- GKFO LLC
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.